Natanja Slager

Title: Natanja Slager: Innovator in Ophthalmic Treatments

Introduction

Natanja Slager is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of ophthalmology, particularly in the treatment of eye disorders. With a total of 2 patents to her name, her work focuses on innovative methods that aim to improve eye health and prevent vision loss.

Latest Patents

Natanja's latest patents revolve around methods for treating eye disorders. One of her notable inventions involves compositions and methods for inhibiting the loss of retinal ganglion cells in subjects. This invention comprises non-invasively applying an ophthalmic composition to the surface of the eye, which includes a therapeutically effective amount of at least one siRNA. This siRNA down-regulates the expression of target genes associated with the loss of retinal ganglion cells, thereby providing a potential treatment for individuals suffering from related eye disorders.

Career Highlights

Natanja Slager is currently associated with Quark Pharmaceuticals, Inc., where she continues to advance her research and development efforts in ophthalmic treatments. Her innovative approach and dedication to improving eye health have positioned her as a key figure in her field.

Collaborations

Throughout her career, Natanja has collaborated with talented individuals such as Elena Feinstein and Evgenia Alpert. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking treatments.

Conclusion

Natanja Slager's contributions to the field of ophthalmology through her innovative patents and collaborations highlight her commitment to advancing eye care. Her work has the potential to significantly impact the treatment of eye disorders and improve the quality of life for many individuals.